SRES696Introduced

A resolution expressing support for the designation of the month of April 2026 as "Parkinson's Awareness Month".

Share:
Introduced
2
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-04-28
Introduced
2
Cosponsors
SRES
Type

Sponsor

Rick Scott
Rick Scott
Republican · FL · Senator
Votes with party: 73.4% (856 recorded votes)
Top industries funding sponsor:
  • Conservative Groups$380k

Full profile: /officials/S001217

Source: Congress.gov · FEC

Cosponsors (2)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2076-2077; text: CR S2085-2086)

2026-04-28

Source: Congress.gov

Plain-English Summary

Congress is officially recognizing April 2026 as "Parkinson's Awareness Month" to draw attention to Parkinson's disease, a neurological condition that affects movement and causes symptoms like tremors and stiffness. This designation encourages people, organizations, and government agencies to raise awareness about the disease, support research efforts, and help patients and their families understand available resources and treatments. The resolution passed unanimously in the Senate without any changes.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. Res. 696 Agreed to Senate (ATS)] <DOC> 119th CONGRESS 2d Session S. RES. 696 Expressing support for the designation of the month of April 2026 as ``Parkinson's Awareness Month''. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES April 28, 2026 Mr. Scott of Florida (for himself, Mr. Booker, and Mr. Risch) submitted the following resolution; which was considered and agreed to _______________________________________________________________________ RESOLUTION Expressing support for the designation of the month of April 2026 as ``Parkinson's Awareness Month''. Whereas Parkinson's disease-- (1) affects over 1,000,000 individuals in the United States with nearly 90,000 individuals diagnosed each year; (2) is the fastest-growing and second most common neurodegenerative disease in the world; (3) is believed to be caused by a combination of genetic and environmental factors, but the exact cause in most individuals is still unknown; and (4) is the 13th leading cause of death in the United States, according to the Centers for Disease Control and Prevention; Whereas the symptoms of Parkinson's disease can include dementia and cognitive impairment, tremors, slowness of movement and rigidity, gait and balance difficulties, speech and swallowing difficulties, depression, and a variety of other symptoms; Whereas there are millions of family caregivers, friends, and loved ones whose lives are greatly affected by Parkinson's disease; and Whereas more research, education, and community support services are needed-- (1) to find better treatments and a cure for Parkinson's disease; and (2) to maintain the dignity of individuals living with Parkinson's disease: Now, therefore, be it Resolved, That the Senate-- (1) expresses support for the designation of the month of April 2026 as ``Parkinson's Awareness Month''; (2) supports the goals and ideals of Parkinson's Awareness Month; (3) continues to support research to find better treatments and a cure for Parkinson's disease; (4) recognizes the individuals living with Parkinson's disease who participate in vital clinical trials to advance the knowledge of the disease; and (5) commends the dedication of organizations, volunteers, researchers, and millions of individuals across the United States working to improve the quality of life of people living with Parkinson's disease and their families. <all>